Spain
Ascires Grupo Médico, a pioneer in Spain for advanced diagnostic imaging, nuclear medicine, and genetic medical services, is recognized as a leader in image-guided radiotherapy oncology. Operating both through public-private hospital partnerships and its own clinics in the Comunidad Valenciana and Cataluña, Ascires has a 60-year legacy and a robust team of over 600 professionals dedicated to healthcare excellence.
The company, founded in 2010, is committed to reinvesting 20% of its annual profits into research and development, emphasizing precision medicine advancements. This includes innovative efforts in artificial intelligence biomarkers and proprietary diagnostic algorithms, ensuring continual progress in personalized patient care.
Despite its significant industry contributions in Health Care and Medical Devices, Ascires has not disclosed recent investment activities, potentially making it an intriguing opportunity for investors seeking to support healthcare innovation within a stable and experienced organization.
